Epidemiology

You have full text access to this OnlineOpen article

Perinatal characteristics and risk of neuroblastoma

  1. Kimberly J. Johnson1,
  2. Susan E. Puumala1,
  3. John T. Soler2,
  4. Logan G. Spector1,3,†,*

Article first published online: 10 JUN 2008

DOI: 10.1002/ijc.23645

Issue

International Journal of Cancer

International Journal of Cancer

Volume 123, Issue 5, pages 1166–1172, 1 September 2008

Additional Information

How to Cite

Johnson, K. J., Puumala, S. E., Soler, J. T. and Spector, L. G. (2008), Perinatal characteristics and risk of neuroblastoma. Int. J. Cancer, 123: 1166–1172. doi: 10.1002/ijc.23645

Author Information

  1. 1

    Division of Epidemiology/Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, MN

  2. 2

    Minnesota Cancer Surveillance System, Minnesota Department of Health, St. Paul, MN

  3. 3

    University of Minnesota Cancer Center, Minneapolis, MN

  1. †

    Fax: +612-624-7147.

*Department of Pediatrics, Division of Epidemiology/Clinical Research, Mayo Mail Code 715, 420 Delaware Street S.E., Minneapolis, MN 55455, USA

Publication History

  1. Issue published online: 17 JUN 2008
  2. Article first published online: 10 JUN 2008
  3. Manuscript Accepted: 19 MAR 2008
  4. Manuscript Received: 25 JAN 2008

Funded by

  • Children's Cancer Research Fund, Minneapolis, MN

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (90K)

References

  • 1
    Goodman MT,Gurney GJ,Smith MA,Olshan AF. Sympathetic nervous system tumors. In: Ries LagSM,GurneyJG,LinetM,TamraT,YoungJL,BuninGR, eds. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. Bethesda: National Institutes of Health, 1999.
  • 2
    Brodeur GM,Maris JM. Neuroblastoma, 4th edn. Philadelphia: Lippincott Williams & Wilkins, 2002.
  • 3
    Maris JM,Hogarty MD,Bagatell R,Cohn SL. Neuroblastoma. Lancet 2007; 369: 2106–20.
  • 4
    Yang Q,Olshan AF,Bondy ML,Shah NR,Pollock BH,Seeger RC,Look AT,Cohn SL. Parental smoking and alcohol consumption and risk of neuroblastoma. Cancer Epidemiol Biomarkers Prev 2000; 9: 967–72.
  • 5
    Kramer S,Ward E,Meadows AT,Malone KE. Medical and drug risk factors associated with neuroblastoma: a case-control study. J Natl Cancer Inst 1987; 78: 797–804.
  • 6
    Buck GM,Michalek AM,Chen CJ,Nasca PC,Baptiste MS. Perinatal factors and risk of neuroblastoma. Paediatr Perinat Epidemiol 2001; 15: 47–53.
    Direct Link:
  • 7
    Schwartzbaum JA. Influence of the mother's prenatal drug consumption on risk of neuroblastoma in the child. Am J Epidemiol 1992; 135: 1358–67.
  • 8
    Schuz J,Kaatsch P,Kaletsch U,Meinert R,Michaelis J. Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 1999; 28: 631–9.
  • 9
    Schuz J,Kaletsch U,Meinert R,Kaatsch P,Spix C,Michaelis J. Risk factors for neuroblastoma at different stages of disease. Results from a population-based case-control study in Germany. J Clin Epidemiol 2001; 54: 702–9.
  • 10
    McLaughlin CC. Perinatal risk factors for childhood cancer. Ph.D. thesis. University at Albany, State University of New York, 2005: 266.
  • 11
    McCall EE,Olshan AF,Daniels JL. Maternal hair dye use and risk of neuroblastoma in offspring. Cancer Causes Control 2005; 16: 743–8.
  • 12
    Michalek AM,Buck GM,Nasca PC,Freedman AN,Baptiste MS,Mahoney MC. Gravid health status, medication use, and risk of neuroblastoma. Am J Epidemiol 1996; 143: 996–1001.
  • 13
    Cook MN,Olshan AF,Guess HA,Savitz DA,Poole C,Blatt J,Bondy ML,Pollock BH. Maternal medication use and neuroblastoma in offspring. Am J Epidemiol 2004; 159: 721–31.
  • 14
    Bluhm EC,Daniels J,Pollock BH,Olshan AF. Maternal use of recreational drugs and neuroblastoma in offspring: a report from the Children's Oncology Group (United States). Cancer Causes Control 2006; 17: 663–9.
  • 15
    Schuz J,Weihkopf T,Kaatsch P. Medication use during pregnancy and the risk of childhood cancer in the offspring. Eur J Paediatr 2007; 166: 433–41.
  • 16
    Johnson CC,Spitz MR. Neuroblastoma: case-control analysis of birth characteristics. J Natl Cancer Inst 1985; 74: 789–92.
  • 17
    Neglia JP,Smithson WA,Gunderson P,King FL,Singher LJ,Robison LL. Prenatal and perinatal risk factors for neuroblastoma. A case-control study. Cancer 1988; 61: 2202–6.
    Direct Link:
  • 18
    Hamrick SE,Olshan AF,Neglia JP,Pollock BH. Association of pregnancy history and birth characteristics with neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. Paediatr Perinat Epidemiol 2001; 15: 328–37.
  • 19
    Urayama KY,Von Behren J,Reynolds P. Birth characteristics and risk of neuroblastoma in young children. Am J Epidemiol 2006.
  • 20
    Chow EJ,Friedman DL,Mueller BA. Maternal and perinatal characteristics in relation to neuroblastoma. Cancer 2007; 109: 983–92.
    Direct Link:
  • 21
    Foulkes WD,Buu PN,Filiatrault D,Leclerc JM,Narod SA. Excess of congenital abnormalities in French-Canadian children with neuroblastoma: a case series study from Montreal. Med Pediatr Oncol 1997; 29: 272–9.
    Direct Link:
  • 22
    Jaro MA. Probabilistic linkage of large public health data files. Stat Med 1995; 14: 491-8.
    Direct Link:
  • 23
    Steliarova-Foucher E,Stiller C,Lacour B,Kaatsch P. International classification of childhood cancer, third edition. Cancer 2005; 103: 1457–67.
    Direct Link:
  • 24
    Brenner WE,Edelman DA,Hendricks CH. A standard of fetal growth for the United States of America. Am J Obstet Gynecol 1976; 126: 555–64.
  • 25
    Langholz B,Jiao J. Computational methods for case-cohort studies. Comput Stat Data Anal 2007; 51: 3737–48.
  • 26
    Schuz J,Forman MR. Birthweight by gestational age and childhood cancer. Cancer Causes Control 2007; 18: 655–63.
  • 27
    Munzer C,Menegaux F,Lacour B,Valteau-Couanet D,Michon J,Coze C,Bergeron C,Auvrignon A,Bernard F,Thomas C,Vannier JP,Kanold J, et al. Birth-related characteristics, congenital malformation, maternal reproductive history and neuroblastoma: the ESCALE study (SFCE). Int J Cancer 2007.
    Direct Link:
  • 28
    Loughhead AM,Fisher AD,Newport DJ,Ritchie JC,Owens MJ,DeVane CL,Stowe ZN. Antidepressants in amniotic fluid: another route of fetal exposure. Am J Psychiatry 2006; 163: 145–7.
  • 29
    Winecker RE,Goldberger BA,Tebbett I,Behnke M,Eyler FD,Conlon M,Wobie K,Karlix J,Bertholf RL. Detection of cocaine and its metabolites in amniotic fluid and umbilical cord tissue. J Anal Toxicol 1997; 21: 97–104.
  • 30
    Syme MR,Paxton JW,Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 2004; 43: 487–514.
  • 31
    Pranzatelli MR,Balletti J. Serotonin receptors in human neuroblastoma: a possible biologic tumor marker. Exp Neurol 1992; 115: 423–7.
  • 32
    Eisensamer B,Rammes G,Gimpl G,Shapa M,Ferrari U,Hapfelmeier G,Bondy B,Parsons C,Gilling K,Zieglgansberger W,Holsboer F,Rupprecht R. Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Mol Psychiatry 2003; 8: 994–1007.
  • 33
    Thompson AJ,Lummis SC. 5-HT3 receptors. Curr Pharm Des 2006; 12: 3615–30.
  • 34
    Buznikov GA,Lambert HW,Lauder JM. Serotonin and serotonin-like substances as regulators of early embryogenesis and morphogenesis. Cell Tissue Res 2001; 305: 177–86.
  • 35
    O'Keane V,Marsh MS. Depression during pregnancy. BMJ 2007; 334: 1003–5.
  • 36
    Acharya S,Jayabose S,Kogan SJ,Tugal O,Beneck D,Leslie D,Slim M. Prenatally diagnosed neuroblastoma. Cancer 1997; 80: 304–10.
    Direct Link:
  • 37
    Maitra A,Kumar V. The endocrine system. In: KumarV,CotranRS,RobbinsSL. Robbins basic pathology,eds. 7th. Philadelphia: Saunders, 2003. 751–2.
  • 38
    Menegaux F,Olshan AF,Reitnauer PJ,Blatt J,Cohn SL. Positive association between congenital anomalies and risk of neuroblastoma. Pediatr Blood Cancer 2005; 45: 649–55.
    Direct Link:
  • 39
    Altmann AE,Halliday JL,Giles GG. Associations between congenital malformations and childhood cancer. A register-based case-control study. Br J Cancer 1998; 78: 1244–49.
  • 40
    Agha MM,Williams JI,Marrett L,T,Zipursky A,Dodds L. Congenital abnormalities and childhood cancer. Cancer 2005; 103: 1939–48.
    Direct Link:
  • 41
    Centers for Disease Control and Prevention. Update on overall prevalence of major birth defects. MMWR Morb Mortal Wkly Rep 2008; 57: 1–5.
  • 42
    Precision and validity in epidemiologic studies. In: RothmanKJ,GreenlandS, eds.Modern epidemiology,2nd edn. Philadelphia: Lippincott-Raven, 1998; 119: 115–34.
  • 43
    Northam S,Knapp TR. The reliability and validity of birth certificates. J Obstet Gynecol Neonatal Nurs 2006; 35: 3–12.
    Direct Link:
  • 44
    Andrade SE,Raebel MA,Brown J,Lane K,Livingston J,Boudreau D,Rolnick SJ,Roblin D,Smith DH,Willy ME,Staffa JA,Platt R. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008; 198: 194e1–5.
  • 45
    Seaverson E,Perkins C,Soler J,Brown M,Bushhouse S. Cancer in Minnesota, 1988–2002. Minneapolis, MN: Minnesota Cancer Surveillance System, Minnesota Department of Health, 2005.
  • 46
    American Cancer Society. Minnesota Cancer Facts and Figures 2006. Atlanta: American Cancer Society; 2006.
View Full Article (HTML) Get PDF (90K)